Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Zrt- and Irt-like protein (ZIP) family, also known as the Solute Carrier Family 39 (SLC39), consists of 14 members in humans that are essential for maintaining cellular zinc homeostasis (Kambe et al., 2015, Physiological Reviews). These transporters primarily function by moving zinc and other divalent metal ions, such as iron and manganese, from the extracellular space or intracellular organelles into the cytoplasm (Jeong and Eide, 2013, Molecular Aspects of Medicine). ZIP proteins play critical roles in various biological processes, including cell signaling, proliferation, and immune function, by regulating the availability of zinc as a structural or catalytic cofactor for thousands of proteins (Hogstrand, 2012, Encyclopedia of Metalloproteins). Dysregulation of ZIP transporters is linked to numerous pathologies, including Acrodermatitis enteropathica (ZIP4 mutations), Ehlers-Danlos syndrome (ZIP13 mutations), and various cancers where specific ZIP members are overexpressed to support rapid cell growth (UniProt Consortium, 2024). Consequently, the ZIP family is an emerging therapeutic target, with research focusing on small molecule inhibitors and antibodies to modulate zinc levels in disease states (Kambe et al., 2015, Physiological Reviews). While direct pharmacological targeting is still largely in the experimental stage, understanding their role in metal transport is vital for developing treatments for metabolic and oncological disorders (Jeong and Eide, 2013, Molecular Aspects of Medicine).
ZIP transporters facilitate the influx of zinc and other divalent cations from the extracellular space or intracellular organelles into the cytosol.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zrt- and Irt-like protein family (ZIP) (ZIP).